We know that the main risk factors such as age and APOE do not follow the correlation expected in advanced stages of AD [64], and we have previously reported [64] that the APOE ε4 genotype had significant effects on the association with FBB-PET global SUVR in SCD subjects. The gene discussed is APOE; the disease is Alzheimer disease.